UK markets close in 8 hours 24 minutes
  • FTSE 100

    6,735.71
    0.00 (0.00%)
     
  • FTSE 250

    20,615.59
    0.00 (0.00%)
     
  • AIM

    1,173.12
    0.00 (0.00%)
     
  • GBP/EUR

    1.1227
    -0.0021 (-0.19%)
     
  • GBP/USD

    1.3558
    -0.0026 (-0.19%)
     
  • BTC-GBP

    26,657.98
    +87.09 (+0.33%)
     
  • CMC Crypto 200

    701.51
    -33.63 (-4.58%)
     
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • DOW

    30,814.26
    -177.24 (-0.57%)
     
  • CRUDE OIL

    52.19
    -0.17 (-0.32%)
     
  • GOLD FUTURES

    1,834.40
    +4.50 (+0.25%)
     
  • NIKKEI 225

    28,242.21
    -276.97 (-0.97%)
     
  • HANG SENG

    28,845.51
    +271.65 (+0.95%)
     
  • DAX

    13,787.73
    -137.37 (-0.99%)
     
  • CAC 40

    5,611.69
    0.00 (0.00%)
     

Global Biochips Research Report 2020: Technology, Markets & Company Forecasts to 2023 & 2028

Research and Markets
·2-min read

Dublin, Dec. 18, 2020 (GLOBE NEWSWIRE) -- The "Biochips - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for the estimation of markets.

Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics, and nanobiotechnology-based nano-arrays.

Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine

The report provides the current share of each segment: market size in 2018 and projected value for the years 2023 and 2028. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics.

The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. The impact of next-generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.

Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 94 companies are included along with a listing of 120+ collaborations between companies. The text is supplemented by 21 tables, 11 figures, and 140 references to literature.

Key Topics Covered:

Executive Summary

1. Introduction

2. Biochip and Microarray Technologies

3. Microfluidics-based Biochips and Microarrays

4. Protein Biochips

5. Nanobiotechnology-based Biochips & Microarrays

6. Biochips & Microarrays for Epigenetics

7. Applications of Microarrays in Drug Discovery & Development

8. Biochips for Biomarkers, Molecular Diagnostics & Personalized

9. Markets

10. Companies

11. References

For more information about this report visit https://www.researchandmarkets.com/r/j18vde

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900